Corticosteroid therapy in Kawasaki disease (KD): Preliminary report of a pilot study of combined IVIG and pulse methylprednisolone as initial treatment.

被引：0

|

作者：

Sundel, RP

Baker, A

Fulton, DR

Eberhard, BA

Newburger, JW

机构：

来源：

ARTHRITIS AND RHEUMATISM | 1999年 / 42卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1463

引用

收藏

页码：S315 / S315

页数：1

相关论文

共 46 条

[41] To amitriptyline: Exploratory pilot study of the French center (A report from the Who project on the combined utilization of an antidepressant (amitriptyline) and an antioxidant (ginkgo biloba) in the treatment of therapy-resistant depression) - Discussion
不详
ANNALES MEDICO-PSYCHOLOGIQUES, 1996, 154 (03): : 203 - 203
[42] Prolonged administration of anti-Interleukin-2 receptor monoclonal antibody therapy for severe steroid-refractory acute graft-versus-host disease: preliminary report of a pilot study
Soumelis, V
Delarue, R
Hirsch, I
Benettaib, B
Hermine, O
Besson, C
Varet, B
Buzyn, A
BONE MARROW TRANSPLANTATION, 2003, 31 : S141 - S141
[43] Prolonged administration of anti-interleukin-2 receptor monoclonal antibody therapy for severe steroid-refractory acute graft versus host disease: Preliminary report of a pilot study.
Soumelis, V
Delarue, R
Benettaib, B
Hirsch, I
Varet, B
Buzyn, A
BLOOD, 2002, 100 (11) : 444B - 444B
[44] Primary central nervous system non-Hodgkin's lymphoma (PCNSL): Survival advantages with combined initial therapy? A final report of the North Central Cancer Treatment Group (NCCTG) study 86-72-52
O'Neill, BP
Wang, CH
O'Fallon, JR
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (03): : 559 - 563
[45] COMBINED MODALITY TREATMENT IN OVER 200 CHILDREN WITH HODGKINS-DISEASE - RISK-ADAPTED CHEMOTHERAPY, LOW-DOSE INVOLVED FIELD IRRADIATION AND SELECTIVE SPLENECTOMY - A REPORT OF THE COOPERATIVE THERAPY STUDY DAL-HD-82
SCHELLONG, G
BRAMSWIG, J
LUDWIG, R
GEREIN, V
JOBKE, A
JURGENS, H
KABISCH, H
STOLLMANN, B
WEINEL, P
GADNER, H
SCHWARZE, EW
WANNENMACHER, M
KLINISCHE PADIATRIE, 1986, 198 (03): : 137 - 146
[46] Preliminary results of a randomized controlled, open-label, multi-center phase II study of camrelizumab combined with chemotherapy followed by concurrent chemoradiotherapy and camrelizumab consolidation therapy versus standard chemoradiotherapy as first-line treatment for limited-disease small cell lung cancer.
Xu, Yaping
Ni, Jian
Ren, Shengxiang
Xu, Xiaoling
Hu, Min
Xu, Qinghua
Chen, Yun
Zhu, Yaoyao
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)

← 1 2 3 4 5 →